Search

Author/Creator Popovich-Hadari, Noa

1. ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data. (28th January 2022)

Authors:
Moskovitz, Mor; Dudnik, Elizabeth; Shamai, Sivan; Rotenberg, Yakir; Popovich-Hadari, Noa; Wollner, Mira; Zer, Alona; Gottfried, Maya; Mishaeli, Moshe; Rosenberg, Shoshana Keren; Onn, Amir; Merimsky, Ofer; Urban, Damien; Peled, Nir; Maimon, Natalie; Bar, Jair
Journal:
Oncologist
Issue:
Volume 27:Number 1(2022)
Page Start:
e76
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search